乳腺系列

Search documents
奕瑞科技收盘下跌5.22%,滚动市盈率39.27倍,总市值184.16亿元
Sou Hu Cai Jing· 2025-08-14 13:51
Core Viewpoint - Yirui Technology's stock closed at 91.98 yuan, down 5.22%, with a rolling PE ratio of 39.27 times and a total market value of 18.416 billion yuan [1] Company Summary - Yirui Technology specializes in the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tubes [1] - The main products include the universal series, dental series, mammography series, radiotherapy series, industrial series, high-voltage generators, and combination ray sources [1] - For Q1 2025, the company reported revenue of 482 million yuan, a year-on-year decrease of 1.92%, and a net profit of 143 million yuan, a year-on-year increase of 2.74%, with a gross profit margin of 48.92% [1] Industry Summary - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Yirui Technology at the 77th position in the industry ranking [1] - The industry average market value is 11.792 billion yuan, while the median market value is 5.679 billion yuan [2] - Other companies in the industry have varying PE ratios, with the lowest being 11.18 times for Jiuan Medical and the highest being 20.62 times for Antu Biology [2]
奕瑞科技收盘上涨5.79%,滚动市盈率39.92倍,总市值187.20亿元
Sou Hu Cai Jing· 2025-08-11 12:02
Core Viewpoint - Yirui Technology's stock closed at 93.5 yuan, up 5.79%, with a rolling PE ratio of 39.92, marking a new low in 39 days, and a total market value of 18.72 billion yuan [1] Company Summary - Yirui Technology specializes in the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tubes [1] - The main products include the universal series, dental series, mammography series, radiotherapy series, industrial series, high-voltage generators, and combination ray sources [1] - As of the first quarter of 2025, the company reported operating revenue of 482 million yuan, a year-on-year decrease of 1.92%, and a net profit of 143 million yuan, a year-on-year increase of 2.74%, with a gross profit margin of 48.92% [1] Industry Summary - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Yirui Technology at 77th in the industry ranking [1] - As of the first quarter of 2025, 51 institutions hold shares in Yirui Technology, with a total of 17.0041 million shares valued at 1.49 billion yuan [1] - The industry average market value is 11.897 billion yuan, while the median market value is 5.767 billion yuan [2]
奕瑞科技收盘下跌1.01%,滚动市盈率37.80倍,总市值177.29亿元
Sou Hu Cai Jing· 2025-07-11 11:12
Company Overview - Yirui Technology's closing price on July 11 was 88.55 yuan, down 1.01%, with a rolling PE ratio of 37.80 times and a total market value of 17.729 billion yuan [1] - The company ranks 77th in the medical device industry, which has an average PE ratio of 52.06 times and a median of 37.22 times [1] - As of the first quarter of 2025, 47 institutions held shares in Yirui Technology, including 39 funds, with a total holding of 82.5452 million shares valued at 9.443 billion yuan [1] Business Operations - Yirui Technology focuses on the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tubes [1] - The main product lines include the universal series, dental series, mammography series, radiotherapy series, industrial series, high-voltage generators, and combination ray sources [1] Financial Performance - In the first quarter of 2025, Yirui Technology reported revenue of 482 million yuan, a year-on-year decrease of 1.92%, while net profit was 143 million yuan, an increase of 2.74% [1] - The sales gross margin for the company was 48.92% [1]
奕瑞科技收盘上涨1.02%,滚动市盈率37.78倍,总市值177.19亿元
Sou Hu Cai Jing· 2025-07-01 11:04
Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a stable position within the medical device industry, despite a slight decline in revenue [1] - As of July 1, Yirui Technology's closing price was 88.5 yuan, with a PE ratio of 37.78 times and a total market capitalization of 17.719 billion yuan [1] - The average PE ratio for the medical device industry is 51.70 times, with a median of 37.36 times, positioning Yirui Technology at the 77th rank within the industry [1][2] Group 2 - Yirui Technology reported a revenue of 482 million yuan for Q1 2025, reflecting a year-on-year decrease of 1.92%, while net profit was 143 million yuan, showing a year-on-year increase of 2.74% [1] - The company's gross profit margin stands at 48.92% [1] - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan per shareholder [1]
奕瑞科技收盘下跌1.31%,滚动市盈率37.90倍,总市值177.73亿元
Sou Hu Cai Jing· 2025-06-26 11:52
Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a competitive position within the medical device industry, despite a slight decline in stock price and revenue [1] - As of June 26, Yirui Technology's closing price was 88.77 yuan, down 1.31%, with a rolling PE ratio of 37.90 times and a total market capitalization of 17.773 billion yuan [1] - The average PE ratio for the medical device industry is 49.45 times, with a median of 35.92 times, positioning Yirui Technology at the 80th rank within the industry [1][2] Group 2 - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of Yirui Technology includes the research, production, sales, and service of digital X-ray detectors, high-voltage generators, and other core components [1] - In the latest quarterly report for Q1 2025, Yirui Technology reported an operating income of 482 million yuan, a year-on-year decrease of 1.92%, and a net profit of 143 million yuan, a year-on-year increase of 2.74%, with a gross profit margin of 48.92% [1]